While UnitedHealth remained profitable, its operating earnings for the three months fell sharply to $5.2 billion from $7.9 ...

Shares of Hims & Hers, which has clashed with Novo Nordisk over its sales of compounded glucagon-like peptide inhibitors, rose slightly in the wake of the report, and have more than doubled in value ...

The healthcare sector, including managed-care firms and drug powerhouses, is vastly underperforming the S&P 500 index. Here ...

UnitedHealth Group faces deteriorating margins and earnings, with bearish trends persisting after FY25 Q2 results. Click for ...

Medical care for thousands of Mainers remains uncertain as Northern Light Health and Anthem Blue Cross and Blue Shield ...

UnitedHealth Group is evaluating all operations, CEO Stephen Hemsley said, and exiting markets where rising medical costs threaten profits.